Streptomyces clavuligerus: The Omics Era

Area of Science:

• Microbial genomics and molecular biology
• Antibiotic biosynthesis and regulation
• Metabolomics and secondary metabolite discovery

Background:

• The Streptomyces clavuligerus genome comprises a linear chromosome and four plasmids.
• Previous studies highlighted the importance of plasmids in genome stability and antibiotic production.

Purpose of the Study:

• To elucidate the biosynthesis and regulation of clavulanic acid, cephamycin C, and holomycin using omics approaches.
• To investigate the role of plasmid pSCL4 and regulatory networks in S. clavuligerus.

Main Methods:

• Comparative transcriptomic and proteomic analyses of wild-type and mutant strains.
• Metabolomic profiling to identify novel secondary metabolites.
• Analysis of regulatory networks involving CcaR, ClaR, and other key regulators.

Main Results:

• Deletion of pSCL4 leads to genome instability and affects antibiotic production.
• Detailed characterization of the CcaR activator and its regulatory network controlling antibiotic gene clusters.
• Identification of novel metabolites, including terpenes, and characterization of terpene synthases.
• Confirmation of ClaR as a CcaR-dependent activator in clavulanic acid biosynthesis.

Conclusions:

• Omics tools provide a comprehensive understanding of S. clavuligerus molecular biology.
• This knowledge enhances S. clavuligerus as an industrial platform for antibiotic production.
• Further research can optimize clavulanic acid (CA) yield through genetic and metabolic engineering.